tirzepatida

La molécula que combate la obesidad y ahora promete revolucionar el tratamiento de la apnea del sueño – ELTIEMPO.COM

by

Recent clinical trials have identified that tirzepatide, a dual-action molecule primarily used for weight management and type 2 diabetes, significantly reduces the severity of obstructive sleep apnea (OSA) in adults with obesity. Published findings in the New England Journal of Medicine indicate that participants treated with the medication experienced a substantial decrease in the number … Read more

GLP-1 and Dual GLP-1/GIP Agonists: Transforming the Future of Obesity and Diabetes Treatment

by

GLP-1 receptor agonists have fundamentally altered the clinical approach to managing Type 2 diabetes and obesity. As these therapies continue to gain global prominence, medical professionals are increasingly focused on a critical secondary effect: the impact of rapid weight loss on body composition, specifically the preservation of lean muscle mass. While these medications are effective … Read more